SOLV Solvac S.A.

91.78USD83.50 EUR · EBR0.00%Mkt Cap: 1.96B USDP/E: 13.99

Solvac S.A. operates as a specialty chemicals company in Belgium. It offers specialty polymers, composite materials, soda ash, and silica. Solvac S.A. was incorporated in 1983 and is headquartered in Brussels, Belgium.

Key Statistics

Company
Market Cap1.96B USD
Enterprise Value—
Revenue (TTM)4.14K USD
Gross Profit-2.96M USD
Net Income (TTM)137.74M USD
Revenue/Share0.00 USD
Last Price91.78 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2
CountryBE
SectorBasic Materials
IndustryChemicals
ISINBE0003545531
Valuation
P/E (Trailing)13.99
P/E (Forward)6.25
PEG—
EV/EBITDA—
EV/Revenue—
P/S473551.40
P/B0.68
EPS (TTM)6.56 USD
EPS (Forward)14.67 USD
52W Range
68.5967% of range103.32
52W High103.32 USD
52W Low68.59 USD
Profitability
Gross Margin0.00%
Oper. Margin-98548.35%
EBITDA Margin0.00%
Profit Margin3302181.60%
ROE4.98%
ROA4.59%
ROIC-0.12%
ROCE-0.12%
Growth
Revenue Growth0.00%
Earnings Growth-0.90%
Cash Flow & Leverage
Operating CF-4.31M USD
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity0.06
Current Ratio—
Quick Ratio—
Book Value/Sh134.42 USD
Cash/Share—
Dividends
Fwd Div Rate6.39 USD
Trail. Div Rate6.39 USD
Div. Yield7.00%
5Y Avg Yield4.96%
Payout Ratio89.23%
Ex-Div DateAug 18, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)111.02 USD
Upside (mean)+21.0%
Target Range109.92 USD – 112.12 USD
109.92+21.0% to mean112.12
# Analysts2
Ownership
Shares Out.21.38M
Float—
Insiders82.42%
Institutions0.00%
Technical
SMA 5094.19 (-2.6%)
SMA 20085.78 (+7.0%)
Beta0.51
S&P 52W Chg12.00%
Avg Vol (30d)2.32K
Avg Vol (10d)1.39K
Technical Indicators
RSI (14)43.3
MACD-0.5555
MACD Signal-0.2904
MACD Hist.-0.2651
BB Upper97.01 USD
BB Middle93.38 USD
BB Lower89.74 USD
BB Width7.79%
ATR (14)2.377 USD
Vol Ratio (20d)0.52x

About Solvac (EBR: SOLV)

›

Solvac (EBR: SOLV) is listed on Euronext Brussels, where its shares trade in EUR. It belongs to the Chemicals industry, part of the Basic Materials sector, and reports about 2 employees.

The shares were at 83.50 EUR on 20 November 2026, up 3.1% over 52 weeks. Its 52-week range is 62.40 EUR to 94.00 EUR: the price is 11.2% below the high and 33.8% above the low.

At a market capitalisation of 1.78B EUR, it trades at 14.0 times trailing earnings and 6.3 times forward earnings. The median trailing P/E of its 15 largest Chemicals peers is 14.2, so SOLV is valued in line with them. It pays a dividend yielding 7.00% (it pays out 89% of its earnings), against a median of 4.15% among the dividend payers in that peer group.

Solvac reports return on equity of 5.0% and flat revenue year over year.

Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 2 analysts cover the stock; their mean price target of 101.00 EUR is 21.0% above the current price. The next earnings report is expected on 5 March 2027.